Zobrazeno 1 - 10
of 14
pro vyhledávání: '"O. A. Sukhorukikh"'
Autor:
I. I. Khayrullin, V. V. Omelyanovskiy, R. V. Gostishchev, O. A. Sukhorukikh, S. A. Kovaleva, B. G. Gorodetsky
Publikováno v:
Фармакоэкономика, Vol 17, Iss 2, Pp 232-242 (2024)
Background. Determining the cost of laboratory tests is a significant factor in the context of economic analysis and management of clinical diagnostic laboratories. Information about costs allows medical organizations to plan operational activities m
Externí odkaz:
https://doaj.org/article/d7aa069604f64236ad5fa3b6ad43973a
Autor:
N. Z. Musina, V. V. Omelyanovskiy, R. V. Gostischev, O. A. Sukhorukikh, V. K. Fedyaeva, N. N. Sisigina, D. G. Shchurov
Publikováno v:
Фармакоэкономика, Vol 13, Iss 4, Pp 438-451 (2021)
This article contains the aims and main principles of the concept of value-based healthcare (VBHC). The relevance of the implementation of this approach into the Russian healthcare system results from the fact that during the control and payment for
Externí odkaz:
https://doaj.org/article/ac432edf7d1146239fa449db35811c2b
Publikováno v:
Фармакоэкономика, Vol 12, Iss 4, Pp 327-332 (2020)
Introduction. The RAND/UCLA system is commonly used in healthcare economics as it allows one to consider both the relevant scientific data and the opinion of leading experts for deciding on the specifics of medical care.Objective. To analyze the reco
Externí odkaz:
https://doaj.org/article/3e1e89bbd1ce4eec869c4a74c2c09521
Autor:
V. K. Fedyaeva, U. N. Dmitrieva, N. I. Juravleva, N. I. Juravlev, M. Yu. Kovaleva, A. S. Korobkina, O. A. Sukhorukikh, A. A. Pashkina
Publikováno v:
Фармакоэкономика, Vol 12, Iss 3, Pp 239-245 (2019)
Introduction. In 2016-2018, the approaches to the development and use of clinical guidelines in the Russian Federation underwent substantial changes. As part of this work, legal aspects of clinical guidelines were modified. The present review, conduc
Externí odkaz:
https://doaj.org/article/b0bac563adb34db29912a9bae9dd588c
Publikováno v:
Фармакоэкономика, Vol 12, Iss 1, Pp 34-41 (2019)
Aim – analyze the existing systems for assessing the levels of evidence (LE-scales) and grades of recommendation (GR-scales) in the development of clinical guidelines in the Russian Federation. Materials and Methods. We analyzed the LE- and GR-scal
Externí odkaz:
https://doaj.org/article/88fff76ed70f4108be15c80d411bd94a
Autor:
V. M. Vatolin, O. A. Sukhorukikh, Zh. A. Galeeva, D. V. Lukyantseva, O. O. Buzuverova, O. V. Kirsanova, E. M. Murtazina, D. G. Ilyukhin, L. S. Shubina
Publikováno v:
Фармакоэкономика, Vol 11, Iss 1, Pp 56-63 (2018)
One of the key elements of medical care is the assessment of the patient’s condition, which allows making a diagnosis and evaluating the patient’s health status, the severity of the disease and the prognosis of its outcome. To date, medical profe
Externí odkaz:
https://doaj.org/article/a18a4dfab5fa4fe6a2eb7e9cbb83a4f5
Publikováno v:
Фармакоэкономика, Vol 11, Iss 1, Pp 45-49 (2018)
The article presents a review of the international experience on the assessment of medical care in outpatients. General approaches, benefits, risks and other criteria of quality assessment are described.
Externí odkaz:
https://doaj.org/article/d62ba5c91ad44b82abe707e0b648dddd
Autor:
D. G. Shchurov, N. N. Sisigina, V. K. Fedyaeva, R. V. Gostischev, O. A. Sukhorukikh, V. V. Omelyanovskiy, N. Z. Musina
Publikováno v:
Фармакоэкономика, Vol 13, Iss 4, Pp 438-451 (2021)
This article contains the aims and main principles of the concept of value-based healthcare (VBHC). The relevance of the implementation of this approach into the Russian healthcare system results from the fact that during the control and payment for
Autor:
A. A. Pashkina, A. S. Korobkina, V. K. Fedyaeva, M. Yu. Kovaleva, N. I. Juravleva, O. A. Sukhorukikh, U. N. Dmitrieva, N. I. Juravlev
Publikováno v:
Фармакоэкономика, Vol 12, Iss 3, Pp 239-245 (2019)
Introduction. In 2016-2018, the approaches to the development and use of clinical guidelines in the Russian Federation underwent substantial changes. As part of this work, legal aspects of clinical guidelines were modified. The present review, conduc
Publikováno v:
Фармакоэкономика, Vol 12, Iss 1, Pp 34-41 (2019)
Aim – analyze the existing systems for assessing the levels of evidence (LE-scales) and grades of recommendation (GR-scales) in the development of clinical guidelines in the Russian Federation. Materials and Methods. We analyzed the LE- and GR-scal